Treeline Biosciences Overview

  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $735M
Latest Deal Amount
  • Investors
  • 7

Treeline Biosciences General Information

Description

Developer of transformative precision medicines for patients intended to treat cancer and other serious conditions. The company is currently operating in stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 68 Southfield Avenuesuite 100
  • Stamford, CT 06902
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Treeline Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 12-Apr-2021 $735M 00000 00.000 Completed Stealth
To view Treeline Biosciences’s complete valuation and funding history, request access »

Treeline Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Treeline Biosciences’s complete cap table history, request access »

Treeline Biosciences Executive Team (2)

Name Title Board Seat Contact Info
Jeffrey Engelman Ph.D Co-Founder & Chief Scientific Officer
Joshua Bilenker MD Co-Founder & Chief Executive Officer
To view Treeline Biosciences’s complete executive team members history, request access »

Treeline Biosciences Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Access Industries Corporation Minority 000 0000 000000 0
Aisling Capital Venture Capital Minority 000 0000 000000 0
Ajax Health Other Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Casdin Capital Hedge Fund Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »